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In the adult pancreas, there has been a long-standing dispute as to whether stem/precursor populations that
retain plasticity to differentiate into endocrine or acinar cell types exist in ducts.We previously reported that
adult Sox9-expressing duct cells are sufficiently plastic to supply new acinar cells in Sox9-IRES-CreERT2
knock-in mice. In the present study, using Sox9-IRES-CreERT2 knock-in mice as a model, we aimed to
analyze how plasticity is controlled in adult ducts. Adult duct cells in these mice express less Sox9 than do
wild-type mice but Hes1 equally. Acinar cell differentiation was accelerated by Hes1 inactivation, but
suppressed by NICD induction in adult Sox9-expressing cells. Quantitative analyses showed that Sox9
expression increased with the induction of NICD but did not change withHes1 inactivation, suggesting that
Notch regulatesHes1 and Sox9 in parallel. Taken together, these findings suggest thatHes1-mediatedNotch
activity determines the plasticity of adult pancreatic duct cells and that theremay exist a dosage requirement
of Sox9 for keeping the duct cell identity in the adult pancreas. In contrast to the extended capability of
acinar cell differentiation by Hes1 inactivation, we obtained no evidence of islet neogenesis from
Hes1-depleted duct cells in physiological or PDL-induced injured conditions.
D
uring organogenesis, the plasticity of embryonic cells gradually decreases as lineage separation proceeds
and cells differentiate into mature cell types. However, the generation of iPS cells and the direct repro-
gramming of some cell types into others clearly show the astonishing plasticity that is retained in adult
cells1,2. The reprogramming can be created by artificially introducing a few transcription factors, and the plasticity
of adult cells is shown in several physiological and pathological conditions, including organ maintenance, tissue
regeneration and carcinogenesis. Indeed, organ-specific stem/progenitor cells have been identified in adult
organs that continuously supply new cells, such as the skin and gut, where they maintain physiological organ
homeostasis3,4. Other reports have shown the dedifferentiation of mature cells into an immature status during the
regeneration process after injury5–7. In addition, pathological metaplasia of mature cell types sometimes causes
malignant transformation8–10. However, in contrast with our understanding of the cell differentiation machinery
during embryonic stages, details of the mechanism that controls adult cell plasticity in vivo largely remain to be
elucidated.
There has been long-standing debate as to whether physiologically functioning stem/progenitor cell popula-
tions exist in the adult ductal compartment of the pancreas11. Several lineage-tracing experiments have been
conducted to follow the fate of adult pancreatic duct cells in vivo, but conflicting results have left this question
unanswered. Solar et al. demonstrated that adult Hnf1b1 cells do not differentiate into acinar or endocrine cells12.
In addition, a cell-tracking experiment of adult Hes11 cells found no evidence of acinar or endocrine differ-
entiation13. However, these reports do not completely refute the existence of stem/progenitor cells in the adult
ductal structure, because the expression of neither Hnf1b nor Hes1 represents the entire adult ductal epithelium.














should be addressed to
Y.K. (yoshiyak@cira.
kyoto-u.ac.jp)
SCIENTIFIC REPORTS | 5 : 8518 | DOI: 10.1038/srep08518 1
experiments to demonstrate the continuous supply of new acinar
cells from the adult Sox9-expressing ductal component in Sox9-
IRES-CreER knock-in (Sox9CreERT2) mice14. Considering the pancre-
atic exocrine structure, centroacinar cells that localize at the tip of the
Sox9-expressing ductal structure are thought to be the best candidate
for acinar progenitors that function in keeping physiological home-
ostasis in Sox9CreERT2 mice. However, another lineage-tracing experi-
ment using BAC Sox9-CreER transgenic mice provided no evidence
of acinar cell differentiation from adult Sox91 cells15. Therefore,
exploration of the mechanism by which new acinar cells are supplied
from the Sox9-expressing cells in Sox9CreERT2 mice should provide
insights into the plasticity of adult pancreatic duct/centroacinar cells.
During embryonic stages, several transcription factors and signals
control cell differentiation machineries in pancreas organogenesis16.
For example, the amounts of expressed Sox9 and Ptf1a have been
shown to influence the differentiation of endocrine and exocrine
lineages, respectively17,18. In addition, many reports have revealed
the pivotal role of Notch signaling in pancreas formation: overex-
pression of the Notch intracellular domain (NICD) suppresses endo-
crine and exocrine differentiation19–21, while inactivation ofHes1, the
main effector of Notch signaling, causes inadequate expansion of
pancreatic progenitors and early premature differentiation resulting
in hypoplastic pancreas formation22–24. While the effect of the dosage
of transcription factors such as Sox9 and Ptf1a has not been fully
investigated in the adult organ, that pancreatic regeneration after
cerulein-induced pancreatitis requires the reactivation of Notch sig-
naling inmice supports the notion that Notch signaling is involved in
controlling adult pancreatic cell plasticity25. In addition, Kopinke et
al. reported that Hes11 duct cells do not normally differentiate into
acinar cells, but do exhibit rapid differentiation into the acinar cell
type after inactivation of Rbpj in Hes1-CreER knock-in mice13,26.
In the present study, we aimed to analyze how the differentiation
ability of Sox91 cells into acinar cells is controlled in Sox9CreERT2
mice. We revealed that Sox9 expression is decreased but that Hes1-
mediated Notch signaling is normally conserved in the pancreas of
adult Sox9CreERT2 mice. Hes1-depletion accelerates acinar cell differ-
entiation from Sox9-expressing duct cells in Sox9CreERT2 mice,
whereas NICD induction suppresses it. In addition, we show that
Notch signaling positively regulates Sox9 and Hes1 in parallel. Based
on these findings, we propose that the strength of Hes1-mediated
Notch signaling and the dosage of Sox9 expression function coop-
eratively to control the plasticity of adult pancreatic duct cells.
Results
Pancreatic Sox9 expression is not altered in neonates but is
reduced in adult Sox9-IRES-CreER knock-in mice. In Sox9CreERT2
mice, the IRES-CreER cassette is inserted in the 39UTR of the Sox9
locus, thus the altered structure of the Sox9 locus potentially disrupts
the control machinery of Sox9 expression in Sox9CreERT2 mice27. At
postnatal day 1 (P1),Western blotting and quantitative PCR analyses
showed no difference in the expression of Sox9 between wild-type
and Sox9CreERT2 heterozygous mice (Fig. 1A). However, at the adult
stage, Sox9 expression in Sox9CreERT2 heterozygous mice was reduced
to 80 6 4.3% and 59 6 12% of that in age-matched wild-type mice at
the protein andmRNA level, respectively (Fig. 1B). The expression of
Sox9 was restricted to CK19-expressing duct/centroacinar cells and
the ratio of Sox9-expressing cells among total pancreatic epithelial
cells was the same in wild-type and Sox9CreERT2 mice both at the
neonatal stage and adulthood (Fig. 1A, B bottom right panels and
Supplementary Table S1), indicating that pancreatic duct/
centroacinar cells in Sox9CreERT2 mice express an equal amount of
Figure 1 | Reduced Sox9 expression in the adult pancreas of Sox9CreERT2 mice. At the neonatal stage (A), the relative expression level of Sox9 in the
pancreata of Sox9CreERT2mice is the same as that of wild-typemice as shown byWestern blot (upper panels, n5 3 each) and qPCR (bottom left panel, n5 3
each). In the adult pancreas (B), Sox9 expression is less in Sox9CreERT2 mice than in wild-type mice (Western blot shown in upper panels, n 5 3 each and
qPCR in bottom left panel, n5 3, 4). The ratio of Sox9-expressing cells among total DAPI1 epithelial cells is not significantly different between wild-type
and Sox9CreERT2mice at P1 or the adult stage (bottom right panels in A andB, n5 3 each, refer to Supplementary Table S1). *P, 0.05.Data are expressed as
means 6 s.e.m.
www.nature.com/scientificreports
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Sox9 in the newborn stage, but less in adulthood than do wild-type
mice.
Expression of Hes1 is the same in adult wild-type and Sox9-IRES-
CreER knock-in mice. Considering a previous report that showed
the inactivation of Rbpj, a main effector of Notch signaling, causes
rapid differentiation of adult Hes1-expressing duct/centroacinar
cells into the acinar cell type26, we questioned if Notch activity is
reduced in the adult pancreas of Sox9CreERT2 mice and evaluated the
activity by Hes1 expression, another main effector of Notch
signaling. Consistent with previous findings on wild-type
mice13,15,28, our immunohistochemical analyses revealed that Hes1
is periodically expressed in the Sox91 ductal compartment,
including the centroacinar cells in the adult pancreas of Sox9CreERT2
mice (Fig. 2A). Quantitatively, up to 63.6 6 1.57% of CK191 duct/
centroacinar cells were positive for Hes1 in Sox9CreERT2 mice, which
was not significantly different from wild-type mice (Fig. 2B, C and
Supplementary Table S2). Hes1 expression was also observed in a
subset of Pecam1 endothelial cells (Fig. 2B) and islets (data not
shown), but we detected no Hes1 expression in amylase1 acinar
cells (Fig. 2B). Quantitative PCR analyses showed no difference in
Hes1 mRNA amounts between adult wild-type and adult Sox9CreERT2
mice (Fig. 2C). Taken together, we concluded that Hes1 expression is
reduced nomore in the pancreas of adult Sox9CreERT2mice than it is in
the pancreas of wild-type mice.
Notch signaling controls the differentiation ability of Sox91
duct/centroacinar cells into the acinar cell type in adult Sox9-
IRES-CreER knock-in mice. We next questioned whether the
modulation of Notch activity influences the differentiation ability
of adult Sox91 duct/centroacinar cells in Sox9CreERT2 mice. For this
purpose, we designed two sets of tamoxifen-inducible Cre-mediated
experiments and evaluated the number of lineage-labeled acinar cells
(Fig. 3A). First, we bred Sox9CreERT2; Hes1loxp/loxp; Rosa26R mice, in
which Sox91 cells have Hes1 null status due to tamoxifen-induced
recombination. The second experiment inducibly forced the
expression of NICD, which constitutively activates Notch signaling
in Sox91 cells from Sox9CreERT2; RosaNICD; Rosa26R mice. In both
experiments, tamoxifen treatment caused nuclear localization of
the CreERT2 protein, and CreERT2-mediated recombination
excised out the STOP cassette of the Rosa26R allele and activated
lacZ expression to enable the detection of the recombined cells and
their progeny as X-gal-positive cells (Fig. 3A). Without tamoxifen
administration, no X-gal positive cells were detected in all
experimental settings (Supplementary Fig. S1), thus the difference
in the number of X-gal positive acinar cells is expected to represent
the difference in the differentiation ability of lineage-labeled duct/
centroacinar cells provided that both the Rosa26R allele and Hes1loxP
or NICD allele are recombined (see below).
As we have previously demonstrated14, the number of X-gal-pos-
itive acinar cells gradually increases after a single injection of tamox-
ifen (0.2 mg/g body weight) in Sox9CreERT2; Hes11/1; Rosa26R mice,
suggesting a continuous acinar cell supply from the Sox9-expressing
duct/centroacinar cell compartment (Fig. 3B, C, E). While a 50%
reduction of Hes1 dosage caused no apparent change in the number
of labeled acinar cells in Sox9CreERT2; Hes1loxp/1; Rosa26R mice, con-
ditional Hes1 depletion in Sox9CreERT2; Hes1loxp/loxp; Rosa26R mice
resulted in accelerated acinar cell labeling (Fig. 3B, C).
Quantitatively, the average number of X-gal-positive acinar cells
was 1140 and 2859 at days 3 and 10 after tamoxifen injection,
respectively, in Sox9CreERT2; Hes1loxp/loxp; Rosa26R mice, which was
larger than the 594 cells and 1741 cells in control Sox9CreERT2;
Hes11/1; Rosa26R mice (Fig. 3C and Supplementary Table S3). On
the contrary, forced expression of NICD caused a decrease in the
number of lineage-labeled acinar cells (Fig. 3D, E), as the average
number of X-gal-positive acinar cells in Sox9CreERT2; RosaNICD;
Rosa26R mice was 308 and 857 at days 3 and 10 (Fig. 3E and
Supplementary Table S3).
Results of the lineage tracing experiments above indicate that
Notch signaling negatively regulates the differentiation ability of
Sox9-expressing progenitors into the acinar cell type in adult
Sox9CreERT2mice. However, this conclusion requires further examina-
tion of whether lineage-labeled cells eventually depleted Hes1 and
induced NICD expression in Sox9CreERT2; Hes1loxp/loxp; Rosa26R mice
and Sox9CreERT2; RosaNICD; Rosa26R mice, respectively. Since Hes1 is
not expressed in acinar cells at steady state (Fig. 2B), it is impossible
to dismiss the existence of lineage-labeled acinar cells that escaped
the recombination of the Hes1loxP allele in Sox9CreERT2; Hes1loxp/loxp;
Rosa26R mice by immunostaining of Hes1. However, even if the
existence of these escaper cells is taken into consideration, activated
differentiation into the acinar cell type is supported by the following
observation:Hes1/X-gal double positive cells were not detected in the
duct/centroacinar compartment, whereas Hes1 expression was pre-
served in X-gal negative ducts at the same frequency as that in wild
type or Sox9CreERT2 mice without tamoxifen treatment (Fig. 2 and
Supplementary Fig. S2A). In addition, the ratio of cell proliferation
to cell death remained the same in Sox9CreERT2; Hes1loxp/loxp; Rosa26R
mice (data not shown). In Sox9CreERT2; RosaNICD; Rosa26R mice, we
tested EGFP expression, which was co-induced with NICD by Cre-
mediated activation of the NICD-IRES-EGFP cassette (Fig. 3A), and
found that lineage-labeled acinar cells contained EGFP-negative cells
(Supplementary Fig. S2B). Therefore, the results in Fig. 3E under-
estimate the impact of suppressed acinar differentiation by NICD
induction. On the other hand, the existence of EGFP/X-gal double
positive acinar cells indicates that NICD induction does not comple-
tely block the differentiation of duct/centroacinar cells into the acinar
cell type in Sox9CreERT2; RosaNICD; Rosa26R mice (Supplementary Fig.
S2B). This notion was confirmed by the existence of Hes1/X-gal
double positive acinar cells (Supplementary Fig. S2B). These findings
indicate that activated Notch activity suppresses but does not com-
pletely block the acinar cell supply from the duct/centroacinar com-
partment in adult Sox9CreERT2 mice, a property that contrasts the
complete acinar cell agenesis by NICD induction during embryonic
stages19,20.
It was reported that rapid differentiation into acinar cell types
caused by Rbpj depletion in Hes1-expressing cells is accompanied
by the loss of a centroacinar cell population26. However, Hes1 seems
to be dispensable for the long-termmaintenance of organ homeosta-
sis in Sox9CreERT2 mice, as centroacinar cells were not lost and the
normal acinar structure was maintained in Sox9CreERT2; Hes1loxp/loxp;
Rosa26R mice, suggesting the existence of a compensatory
machinery. In fact, our lineage-tracing experiments using
Sox9CreERT2; Hes1loxp/loxp; Rosa26R mice showed that both the duct
and acinar cells retained their labeling status up to one year after
tamoxifen injection (Supplementary Fig. S3A), indicating that
Sox9-expressing duct/centroacinar cells could self-duplicate and
continuously supply new acinar cells after Hes1 depletion. In addi-
tion, X-gal-labeled endocrine cells were not observed, indicating that
Hes1 inactivation did not induce transdifferentiation of duct cells
into endocrine cells in the adult pancreas (Supplementary Fig. S3B).
Ptf1a expression is not influenced by the modulation of notch
signaling in the adult pancreas. While its role in the adult pancreas
is still unknown, Ptf1a is indispensable for acinar cell differentiation29–31
and Notch signaling negatively regulates Ptf1a expression22,32,33 during
pancreatogenesis. Considering the continuous acinar cell supply from
the Sox91 component in adult Sox9CreERT2mice, we questioned whether
Ptf1a is ectopically expressed in Sox91 cells, especially in centroacinar
cells in adult Sox9CreERT2 mice and whether modulation of Notch activity
affects Ptf1a expression. However, as shown in Fig. 4A, Ptf1a expression
is confined to acinar cells and not detected in the CK19-positive ductal
structure, which includes centroacinar cells at steady state (Sox9CreERT2;
www.nature.com/scientificreports
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Figure 2 | Unaltered Notch signal in adult Sox9CreERT2 mice at steady state. (A) In the adult pancreas of Sox9CreERT2 mice, Hes1 is expressed in a
subpopulation of Sox91 duct/centroacinar cells. White and yellow arrowheads indicate Sox9 single positive and Sox9/Hes1 double positive duct/
centroacinar cells, respectively. The same section was used for both images. Scale bars 5 25 mm. (B) Periodical expression of Hes1 in the ductal tree is
confirmed by co-immunostaining of Hes1 and CK19 (upper panels). Note that Hes1 is expressed in a subset of Pecam-expressing endothelial cells (white
arrowheads in the middle panels) but not in amylase1 acinar cells (bottom panels) in the adult pancreas of Sox9CreERT2 mice. Scale bars 5 25 mm. (C) In
adult Sox9CreERT2mice, the ratio of Hes11 cells to total CK191 duct/centroacinar cells is unaltered compared with that of wild-typemice (left, n5 3 each,
refer to Supplementary Table S2). qRT-PCR revealed that the Hes1mRNA amount is the same in adult Sox9CreERT2 and wild-typemice (right, n5 3 each).
Data are expressed as means 6 s.e.m.
www.nature.com/scientificreports
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Hes11/1; Rosa26R mice). Additionally, it was affected by neither Hes1
depletion nor NICD induction, indicating that Notch-mediated Ptf1a
suppression is less robust at adult stages than at embryonic stages.
Indeed, Ptf1a expression was not detected in X-gal-positive duct cells
of Sox9CreERT2; Hes1loxp/loxp; Rosa26R mice, confirming Hes1 depletion
(Supplementary Fig. S2A). Furthermore, we treated mice with a
higher dosage of tamoxifen (four injections of 0.2 mg/g body weight),
which achieved more efficient labeling (approximately 60%, data not
shown) of Sox91 duct cells in control mice (Supplementary Fig. S4A).
Efficient recombination was confirmed by observing a decrease and
Figure 3 | Notch signaling regulates the ability of duct-to-acinar differentiation in adult Sox9CreERT2 mice. (A) Experimental strategy of tamoxifen-
inducible Cre-mediated lineage tracing (upper panel) and Notch modulation in Sox91 cells (middle panel, Hes1 depletion; lower panel, NICD
induction). (B andD)Representative sections with X-gal staining 3 days and 10 days after single tamoxifen injection. X-gal-positive acinar cells, progenies
of Sox9-expressing duct/centroacinar cells, increased fromday 3 to day 10 in all the transgenicmice tested. (C and E)Quantitative analyses of the numbers
of lineage-labeled acinar cells (refer to Supplementary Table S3). Note that conditional Hes1 depletion significantly accelerates acinar cell labeling in
Sox9CreERT2; Hes1loxp/loxp; Rosa26Rmice ((C), blue, P 5 0.026 at day 3, P 5 0.006 at day 10), but heterozygous inactivation (Sox9CreERT2; Hes1loxp/1; Rosa26R
mice, shown in green) does not ((C), P5 0.21 at day 3, P5 0.65 at day 10). Activation of Notch signaling byNICD induction results in reduced acinar cell
labeling in Sox9CreERT2; RosaNICD; Rosa26Rmice compared with Sox9CreERT2; Hes11/1; Rosa26R control mice ((E), red, P 5 0.026 at day 3, P 5 0.007 at day
10). Scale bars 5 100 mm. *P , 0.05, **P , 0.01. Data are expressed as means 6 s.e.m.
www.nature.com/scientificreports
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increase in the number of Hes1-expressing cells in Sox9CreERT2;
Hes1loxp/loxp; Rosa26R mice and Sox9CreERT2; RosaNICD; Rosa26R mice,
respectively (Supplementary Fig. S4B). Again, we detected no ectopic
Ptf1a expression, at least by immunostaining, in the Sox91 ductal
component of Sox9CreERT2; Hes1loxp/loxp; Rosa26R mice (Fig. 4B). In
Sox9CreERT2; RosaNICD; Rosa26R mice, Ptf1a expression was confined to
the Sox9-negative acinar cells (Fig. 4B), including the Hes1-expressing
acinar cells that were formed by NICD induction (Supplementary Fig.
S5). Thus, the expression pattern of Ptf1a was unperturbed by
modulating Notch activity in Sox9CreERT2 mice, as neither Sox9/Ptf1a
double positive cells nor structural alterations were observed.
Notch signaling regulates Sox9 expression in adult pancreatic
duct cells. We found that the Sox9/CK19-expressing ductal
Figure 4 | Ptf1a expression is not altered by Notch modulation in adult Sox9CreERT2 mice. Expression of Ptf1a is confined to acinar cells and not affected
by the modulation of Notch activity. (A) Ptf1a is expressed in lineage-labeled acinar cells (white arrows) and surrounding non-labeled acinar cells
but not in CK19-expressing duct/centroacinar cells (dotted line and yellow arrowheads) in Sox9CreERT2; Hes11/1; Rosa26R mice (left panels), Sox9CreERT2;
Hes1loxp/loxp; Rosa26R mice (middle panels) and Sox9CreERT2; RosaNICD; Rosa26R mice (right panels). The same section was used for X-gal staining and
immunostaining in each column. Scale bars5 25 mm. (B) Ptf1a expression is confirmed by the co-staining of Ptf1a and Sox9 using sections obtained after
high-dose tamoxifen treatment (refer to Supplementary Fig. S4). Scale bars 5 25 mm.
www.nature.com/scientificreports
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component was structurally impaired by neither Hes1 depletion nor
forced expression of NICD (Fig. 5A), even at the higher dosage of
tamoxifen treatment (four injections of 0.2 mg/g body weight).
Further, we did not detect any ectopic Sox9 expression in acinar
cells, and the ratio of Sox91 cells among total DAPI1 epithelial
cells remained constant with modulating Notch activity (Fig. 5B
and Supplementary Table S4). Notably, our Western blotting and
quantitative PCR analyses revealed that the expression of Sox9 was
elevated by the forced expression of NICD (Fig. 5B). On the other
hand, Hes1 depletion did not influence the amount of Sox9 or the
number of Sox9-expressing cells, reflecting the asymmetric division
of Sox91 cells into acinar and Sox91 cells in Sox9CreERT2 mice14.
Thus, considering the increased number of Hes1-expressing cells
by NICD induction (Supplementary Fig. S4 and S5), our findings
show that Notch positively regulates Hes1 and Sox9 in parallel in
adult pancreatic duct cells of Sox9CreERT2 mice and that the regulation
of Sox9 expression by Notch is mediated in a Hes1-independent
manner in the adult pancreas.
Hes1-depleted duct cells do not show endocrine neogenesis after
pancreatic duct ligation. Another long-standing debate is whether
adult pancreatic duct cells possess plasticity to differentiate into the
endocrine lineage. In particular, possible islet neogenesis after
pancreatic duct ligation (PDL) has attracted the interest of
researchers34,35. We previously reported that beta cell neogenesis
from Sox9-expressing duct cells was observed in neither the
physiological condition nor the regeneration process after injury,
including partial pancreatectomy, cerulein-induced acute
pancreatitis, streptozotocin diabetes or PDL, in Sox9CreERT2 mice14.
Because Hes1 inactivation in the embryonic pancreas accelerates
endocrine differentiation23, we tested whether Hes1 depletion
combined with PDL prompts adult Sox9-expressing cells to
differentiate into endocrine lineages in Sox9CreERT2 mice. However,
lineage tracing analyses detected noX-gal-positive cells in the islets at
days 7 or 60 after PDL in Sox9CreERT2; Hes1loxp/loxp; Rosa26R mice
(Fig. 6), indicating that adult Sox9-expressing duct/centroacinar
cells are not capable of differentiating into endocrine lineages even
by the combination of Hes1-inactivation and PDL.
Discussion
In this study, we demonstrated that the plasticity of adult pancreatic
duct cells is controlled by the strength of Notch signaling. The dif-
ferentiation ability of Sox9-expressing duct/centroacinar cells into
acinar cell types was accelerated byHes1 inactivation and suppressed
by NICD induction in Sox9CreERT2 mice. This effect is consistent with
two reports by Kopinke et al. that show Hes1-expressing centroaci-
nar/terminal duct cells do not normally differentiate into acinar cells
but will do so rapidly upon the inactivation of Rbpj in Hes1-CreER
knock-in mice, which suggests that Notch signaling functions to
maintain the duct cell identity in the adult pancreas13,26. Adding to
that our previous report that showed Sox9-expressing duct/centroa-
cinar cells continuously supply new acinar cells in adult Sox9CreERT2
mice14, we hypothesized Hes1-negative/Sox9-positive centroacinar
cells are best candidates for the origin of continuous acinar cell
supply in Sox9CreERT2 mice. However, Notch signaling alone cannot
explain why Sox9-expressing cells were reported not to differentiate
into acinar cells in adult BAC Sox9-CreER transgenic mice15. We
therefore predicted the existence of one or more other mechanisms
that control adult duct cell plasticity.
We propose that the amount of Sox9 expression is pivotal in
controlling adult duct cell plasticity (Fig. 7). The dosage requirement
of Sox9 in the formation of the embryonic endocrine pancreas has
been previously suggested by autopsy samples from three human
cases of campomelic dysplasia, an autosomal dominant disorder
caused by SOX9 haploinsufficiency that has been described as ‘‘less
densely packed epithelial cells within the mesenchymal stroma and
less clearly formed islets36.’’ The dosage requirement has also been
experimentally supported previously; a Pdx1-Cre-mediated 50%
reduction of Sox9 expression caused a decrease in the number of
neurogenin 3 (Ngn3)-expressing endocrine progenitors and less
endocrine formation in Pdx1-Cre; Sox9loxp/1 mice17. However, in
the human campomelic dysplasia cases, little attention was given
to the exocrine tissue36, and exocrine pancreatic formation was not
impaired in Pdx1-Cre; Sox9loxp/1 mice17, suggesting that Sox9 dosage
has less effect on exocrine pancreas formation during the embryonic
stages. In contrast, our results suggest the involvement of Sox9 dos-
age in controlling the plasticity of adult pancreatic duct cells. In the
present study, we demonstrated that pancreatic Sox9 expression in
neonates was the same in wild-type and Sox9CreERT2 mice, whereas
adult pancreatic duct cells express less Sox9 in Sox9CreERT2 mice than
in adult wild-type mice. It should be noted that two previously
reported lineage-tracing experiments using Sox9CreERT2 and BAC
Sox9-CreER transgenic mice are consistent in that embryonic
Sox91 duct cells were sufficiently plastic to differentiate into acinar
and endocrine lineages, an ability that persisted until the perinatal
stages up to one week after birth14,15. Provided that the amount of
Sox9 expression in BAC Sox9-CreER transgenic mice was kept at the
same level as that of wild-type mice at the newborn stage and adult-
hood, reduced Sox9 expression may allow duct cells to differentiate
into acinar cells in adult Sox9CreERT2 mice, whereas higher Sox9
expression in BAC Sox9-CreER transgenic mice possibly functions
to maintain the duct cell identity, thereby preventing continuous
differentiation into acinar cell types.
We also show that the induction of NICD caused elevated Sox9
expression, indicating that Sox9 expression is regulated by Notch
signaling in adult Sox9CreERT2 pancreata. This result is consistent with
Shih et al., who reported that Notch signaling regulates Sox9 express-
ion in the embryonic pancreas37. An in vitro tissue culture experiment
using wild-type pancreas at e12.5 further showed that Hes1 express-
ion was reduced by the addition of a low-dose c-secretase inhibitor,
while Sox9 expression was decreased at a higher dosage, indicating
that Notch regulates Hes1 and Sox9 in parallel in embryonic pan-
creata. Nevertheless, we hypothesized that the reduced Sox9 express-
ion in the adult pancreas of Sox9CreERT2 mice at steady state is
unconnected with Notch-mediated regulation. Notch activity seemed
normal based on the ratio of Hes1-expressing cell numbers to CK-
positive ductal epithelia and the amount of Hes1 mRNA was the
same between wild-type and Sox9CreERT2 mice. In Sox9CreERT2 mice,
the IRES-CreERT2 cassette is inserted in the 39UTR of the Sox9
locus27. We therefore speculate that the altered structure of the
Sox9 locus is related to the reduction of Sox9 expression38 in the adult
pancreas, though the precise machinery has yet to be revealed. Recent
reports showed a conserved sequence among species very near the
site of the IRES-CreERT2 cassette insertion, suggesting the existence
of a regulatory element in this region39,40. Because the Sox9 expression
was normal at the perinatal stage in Sox9CreERT2 mice, Notch-inde-
pendent Sox9 regulation using this element, if it exists, would be silent
until adulthood, when it maintains the Sox9 expression and thereby
maintains the identity of the duct cell type. Future studies to dissect
the complete regulatory machinery of Sox9 are required.
Islet neogenesis has long been believed to occur in the ductal
compartment during the tissue restoration process, but we did not
observe evidence of islet regeneration from Sox9-expressing cells in a
PDL model. Xu et al. showed that the number of Ngn3-positive
endocrine precursor cells increases after PDL34. Furthermore, in
BAC Sox9-CreER transgenic mice, it was reported that de novo
Ngn3-expressing cells are of duct cell origin, but that they do not
express other pivotal transcription factors, such as Nkx6.1 and Pax6,
and thus are unable to drive the entire differentiation program into
endocrine lineage15. Consistent with this observation, Xiao et al.
showed that Ngn3-expressing cells originating from the ducts after
PDL do not differentiate into mature endocrine cells41.
www.nature.com/scientificreports
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Figure 5 | Notch signaling regulates Sox9 expression in adult Sox9CreERT2 mice. Sox9 immunostaining, Western blotting, qPCR and cell counting were
carried out after high-dose tamoxifen treatment (see Supplementary Fig. S4). (A) Neither Hes1 inactivation nor NICD induction causes ectopic
Sox9 expression. Sox9 expression is confined to CK191 duct/centroacinar cells. Scale bars 5 25 mm. (B) Western blotting (upper panels) and the real-
time qRT-PCR analyses (bottom, left panel) show that the expression level of Sox9 is increased by NICD induction (n 5 3, P 5 0.0027 and 0.0003,
respectively) but not influenced byHes1 inactivation (n5 3, P5 0.38 and 0.49, respectively). The ratio of Sox91 cells to totalDAPI1 epithelial cells is not
altered by the modulation of Notch activity (bottom right panel, refer to Supplementary Table S4). *P , 0.05, **P , 0.01. Data are expressed as
means 6 s.e.m.
www.nature.com/scientificreports
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Recent reports have focused more on the plasticity of adult acinar
cells. Inducible Cre-mediated cell tracking using Ptf1a-CreERTM
knock-in mice showed that adult acinar cells differentiate into endo-
crine cells and migrated into the islet structure after PDL35.
Moreover, the plasticity of adult acinar cells has been experimentally
demonstrated in the process of malignant transformation. The
induction of oncogenic KrasG12D in the adult murine acinar cell type
caused PanIN formation via acinar-to-ductal metaplasia (ADM) and
Figure 6 | Hes1-deleted pancreatic duct cells do not contribute to islet neogenesis after PDL. (A) Schematic presentation of the experimental design.
Two days before pancreatic duct ligation (PDL), a single injection of tamoxifen was given. Mice were analyzed 7 days and 60 days after PDL.
(B) X-gal-stained pancreas section at 7 days after PDL. PDL induced acinar cell devastation and a duct-like structure in the ligated portion but not in the
unligated portion. Scale bars5 50 mm. (C) Immunostaining revealed that neither insulin1 nor glucagon1 cells are labeled at 7 days or 60 days after PDL
(n 5 4 for day 7, n 5 3 for day 60). Islets are encircled with dotted lines. Scale bars 5 50 mm.
www.nature.com/scientificreports
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developed into pancreatic ductal adenocarcinoma, whereas KrasG12D
activation in the duct cell type did not42. Interestingly, Sox9/CPA1
double positive cells emerge during the transdifferentiation process
of ADM, and simultaneous Sox9 depletion and KrasG12D activation
does not cause ADM in Ptf1aCreERTM; LSL-KrasG12D; Sox9floxed/floxed;
Rosa26YFP mice42. In addition, our preliminary experimental results
showed the emergence of Sox9/Ptf1a double positive cells in the
tissue restoration after cerulein-induced acute pancreatitis. These
findings suggest that cell plasticity might be connected to the co-
expression of transcription factors that normally defines specific cell
types: Sox9 in duct cells and Ptf1a in adult acinar cells. In fact, Sox9/
Ptf1a double positive cells exist in the early embryonic pancreatic
epithelium from which all pancreatic cell types originate15,35,43. To
note, the Sox9/CPA1 double positive cells and Sox9/Ptf1a double
positive cells mentioned above accompany tissue structure altera-
tions such as ADM, tissue restoration after injury or embryonic
organogenesis, whereas we observed no structural change or Sox9/
Ptf1a double positive cells in the present study. So far, a precise
mechanism that explains the relationship between the degree of cell
plasticity with the co-expression of cell type-specific transcription
factors and tissue construction is lacking. Further examination of
duct-originated diseases, such as intraductal neoplasms, that accom-
pany with tissue destruction may help reveal such a mechanism.
Methods
Mice. To obtain Hes1-conditional knock-out mice, Hes1loxp/1 mice44, Sox9IRES-CreERT2
mice27 and Rosa26LacZ (Rosa26R) mice45 were interbred. Rosa26NICD mice19 and
Sox9IRES-CreERT2; Rosa26R mice were crossed to produce Sox9IRES-CreERT2; Rosa26NICD;
Rosa26R mice. The pancreatic duct ligation (PDL) procedure was performed as
previously described34. All animal experiments were performed in accordance with
the Kyoto University guidelines for animal experiments and approved by the animal
research committee of Kyoto University.
Tamoxifen injection. For lineage tracing, adult mice older than 8 weeks of age
(approximately 25–30 g in body weight) were injected intraperitoneally with
tamoxifen (Sigma T-5648) at 0.2 mg/g body weight. To get higher recombination
efficiency, we injected tamoxifen at 0.2 mg/g body weight 4 times every other day.
Tissue preparation for X-gal staining and paraffin section. X-gal staining and
paraffin section were performed as previously described14.
Immunofluorescence. The antigen retrieval procedure was performed with Target
Retrieval Solution pH 6.0 (Dako), Target Retrieval Solution High pH 9.0 (Dako) or
Proteinase K (Dako) in accordance with the manufacturer’s instructions, followed by
overnight incubation at 4uC with primary antibodies (Supplementary Table S5). The
sections were washed in PBS and incubated for 60 min with secondary antibodies
(Supplementary Table S6), followed by counterstaining with 4, 6-diamidino-2-
phenylindole (DAPI). Immunostaining for Hes1 and Ptf1a required the use of the
TSA amplification Kit (Perkin Elmar). Images were visualized using HS All-in-one
Fluorescence Microscopy BZ-9000E (Keyence).
Cell counting.We chose 20 fields at random and counted X-gal-positive acinar cells
in each mouse. For short-term chase in the adult pancreas, we examined 20 fields per
mouse to count the X-gal-positive acinar cells and averaged them. Cell numbers were
counted by 3200 magnification in 40 fields (at adult stage) and 6 fields (at P1) using
three sections per mouse and the ratio of Sox91 cells among all DAPI1 epithelial
cells was calculated. To determine the ratio of Hes11 cells among CK191 duct cells,
cell numbers were counted by 3400 magnification in 6 fields per mouse. All values
are shown as mean 6 s.e.m. All error bars represent s.e.m. P values were calculated
using an unpaired Student’s t test (two-tailed); P , 0.05 was considered significant.
RNA isolation and RT-PCR. Total RNA was extracted using the RNeasy Mini Kit
(Qiagen). First-strand cDNA synthesis was performed using Rever Tra Ace qPCR RT
Master Mix (Toyobo). Quantitative RT-PCR for Hes1 and Sox9 was performed with
Taq Man and SYBR Green. Independent experiments were performed three times
and confirmed. Data were normalized in relation to the expression of GAPDH and
HPRT1. The Sox9 and Hes1 probes used were TaqMan Gene Expression Assay nos.
Sox95Mm004488402m1, Hes15Mm013428052m1, GAPDH5Mm99999915
2 g1 and HPRT1 5 Mm01545399 2 m1 (Applied Biosystems). For the SYBR Green
DCT method, the Sox9 primer sequences were forward, AGGAAGCTGGCAG-
ACCAGTA and reverse, TCCACGAAGGGTCTCTTCTC; and the GAPDH primer
sequences were forward, GTGTTCCTACCCCCAATGTGT and reverse,
ATTGTCATACCAGGAAATGAGCTT. Analysis was performed using the standard
curve and comparative CT methods. P values were calculated using an unpaired
Student’s t test (two-tailed); P , 0.05 was considered significant.
Western blotting. Whole pancreatic tissues were lysed in RIPA buffer (Thermo
Scientific Pierce) in the presence of protease inhibitor (Roche). Obtained samples
were electrophoresed in 10% SDS-PAGE gels and transferred to PVDF membrane
(Bio-Rad).Membranes were blocked with 5% skimmilk in TBS-T and incubated with
anti-Sox9 antibody (Millipore 15500) or anti-b-actin antibody (MBL 151000)
overnight at 4uC. After washing, membranes were reacted with HRP-conjugated
secondary antibodies (DAKO) at 152000 dilution. Chemiluminescence was detected
with Immobilon Western horseradish peroxidase substrate (Thermo Scientific
Pierce) and visualized with a charge-coupled device camera (Ez-capture). The
intensity of the bands was quantified with imaging analysis software (Image J) using
b-actin as an internal control. P values were calculated using an unpaired Student’s t
test (two-tailed); P , 0.05 was considered significant.
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